The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
Abstract
BACKGROUND: Mild to moderate hypertension during pregnancy is common. Antihypertensive drugs are often used in the belief that lowering blood pressure will prevent progression to more severe disease, and thereby improve outcome. OBJECTIVES: To assess the effects of antihypertensive drug treatments for women with mild to moderate hypertension during pregnancy. SEARCH STRATEGY: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (March 2006), the Cochrane Central Register of Controlled Trials (The Cochrane Library 2005, Issue 3), MEDLINE (1966 to November 2005), LILACS (1984 to November 2005) and EMBASE (1974 to November 2005). SELECTION CRITERIA: All randomised trials evaluating any antihypertensive drug treatment for mild to moderate hypertension during pregnancy defined, whenever possible, as systolic blood pressure 140 to 169 mmHg and diastolic blood pressure 90 to 109 mmHg. Comparisons were of one or more antihypertensive drug(s) with placebo, with no antihypertensive drug, or with another antihypertensive drug, and where treatment was planned to continue for at least seven days. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data. MAIN RESULTS: Forty-six trials (4282 women) were included. Twenty-eight trials compared an antihypertensive drug with placebo/no antihypertensive drug (3200 women). There is a halving in the risk of developing severe hypertension associated with the use of antihypertensive drug(s) (19 trials, 2409 women; relative risk (RR) 0.50; 95% confidence interval (CI) 0.41 to 0.61; risk difference (RD) -0.10 (-0.12 to -0.07); number needed to treat (NNT) 10 (8 to 13)) but little evidence of a difference in the risk of pre-eclampsia (22 trials, 2702 women; RR 0.97; 95% CI 0.83 to 1.13). Similarly, there is no clear effect on the risk of the baby dying (26 trials, 3081 women; RR 0.73; 95% CI 0.50 to 1.08), preterm birth (14 trials, 1992 women; RR 1.02; 95 % CI 0.89 to 1.16), or small-for-gestational-age babies (19 trials, 2437 women; RR 1.04; 95 % CI 0.84 to 1.27). There were no clear differences in any other outcomes. Nineteen trials (1282 women) compared one antihypertensive drug with another. Beta blockers seem better than methyldopa for reducing the risk of severe hypertension (10 trials, 539 women, RR 0.75 (95 % CI 0.59 to 0.94); RD -0.08 (-0.14 to 0.02); NNT 12 (6 to 275)). There is no clear difference between any of the alternative drugs in the risk of developing proteinuria/pre-eclampsia. Other outcomes were only reported by a small proportion of studies, and there were no clear differences. AUTHORS' CONCLUSIONS: It remains unclear whether antihypertensive drug therapy for mild to moderate hypertension during pregnancy is worthwhile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Antiplatelet agents for preventing and treating pre-eclampsia
Knight, M., Duley, L., Henderson‐Smart, D., & King, J. (2000) · doi:10.1002/14651858.cd000492 · Cited by 114
Self-citationRetracted(2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.107928 · Cited by 3,270
Brown, M. A., Lindheimer, M. D., Swiet, M. D., Assche, A. V., & Moutquin, J.-M. (2001) · Hypertension in Pregnancy · doi:10.1081/prg-100104165 · Cited by 1,894
The classification and definition of the hypertensive disorders of pregnancy
Davey, D. A., & MacGillivray, I. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(88)90090-7 · Cited by 1,288
Pre-eclampsia: more than pregnancy-induced hypertension
Roberts, J. M., & Redman, C. W. G. (1993) · The Lancet · doi:10.1016/0140-6736(93)90889-o · Cited by 1,246
Clinical physiology in obstetrics
Eskes, T. K. A. B. (1999) · Radboud Repository (Radboud University) · Cited by 579
von Dadelszen, P., Ornstein, M., Bull, S., Logan, A., Koren, G., & Magee, L. (2000) · The Lancet · doi:10.1016/s0140-6736(98)08049-0 · Cited by 518
(1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90653-o · Cited by 438
The role of nitric oxide in the pathogenesis of preeclampsia
Seligman, S. P., Buyon, J. P., Clancy, R. M., Young, B. K., & Abramson, S. B. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70064-8 · Cited by 377
Cited by
Steegers, E. A., von Dadelszen, P., Duvekot, J. J., & Pijnenborg, R. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60279-6 · Cited by 2,850
Bhutta, Z. A., Das, J. K., Bahl, R., Lawn, J. E., Salam, R. A., Paul, V. K., Sankar, M. J., Blencowe, H., Rizvi, A., Chou, V. B., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60792-3 · Cited by 1,367
Bushnell, C., McCullough, L. D., Awad, I. A., Chireau, M. V., Fedder, W. N., Furie, K. L., Howard, V. J., Lichtman, J. H., Lisabeth, L. D., Piña, I. L., et al. (2014) · Stroke · doi:10.1161/01.str.0000442009.06663.48 · Cited by 941
Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis
Bramham, K., Parnell, B., Nelson-Piercy, C., Seed, P. T., Poston, L., & Chappell, L. C. (2014) · BMJ · doi:10.1136/bmj.g2301 · Cited by 767
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
Abalos, E., Duley, L., & Steyn, D. W. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002252.pub3 · Cited by 705
Self-citationPreeclampsia: Updates in Pathogenesis, Definitions, and Guidelines
Phipps, E., Prasanna, D., Brima, W., & Jim, B. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12081115 · Cited by 622
VI Diretrizes Brasileiras de Hipertensão
(2010) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2010001700001 · Cited by 596
Magnesium sulphate and other anticonvulsants for women with pre-eclampsia
Duley, L., Gülmezoglu, A. M., Henderson-Smart, D. J., & Chou, D. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000025.pub2 · Cited by 586
Self-citationTreatment for mild chronic hypertension during pregnancy
Tita, A. T., Szychowski, J. M., Boggess, K., Dugoff, L., Sibai, B., Lawrence, K., Hughes, B. L., Bell, J., Aagaard, K., Edwards, R. K., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2201295 · Cited by 567
Magee, L. A., Nicolaides, K. H., & von Dadelszen, P. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2109523 · Cited by 546
Managing preexisting diabetes for pregnancy
Kitzmiller, J. L., Block, J. M., Brown, F. M., Catalano, P. M., Conway, D. L., Coustan, D. R., Gunderson, E. P., Herman, W. H., Hoffman, L. D., Inturrisi, M., et al. (2008) · Diabetes Care · doi:10.2337/dc08-9020 · Cited by 476
Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy
Magee, L. A., Pels, A., Helewa, M., Rey, E., & von Dadelszen, P. (2014) · Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health · doi:10.1016/j.preghy.2014.01.003 · Cited by 448
Drugs for treatment of very high blood pressure during pregnancy
Duley, L., Meher, S., & Jones, L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001449.pub3 · Cited by 423
Self-citationPregnancy-Induced hypertension
Kintiraki, E., Papakatsika, S., Kotronis, G., Goulis, D. G., & Kotsis, V. (2015) · Hormones · doi:10.14310/horm.2002.1582 · Cited by 330
Meads, C., Cnossen, J., Meher, S., Juarez-Garcia, A., ter Riet, G., Duley, L., Roberts, T., Mol, B., van der Post, J., Leeflang, M., et al. (2008) · Health Technology Assessment · doi:10.3310/hta12060 · Cited by 323
Self-citationWriting Committee Members*, Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., et al. (2025) · Hypertension · doi:10.1161/hyp.0000000000000249 · Cited by 310
Prediction and Prevention of Recurrent Preeclampsia
Barton, J. R., & Sibai, B. M. (2008) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181801d56 · Cited by 309
A Comprehensive Review of Hypertension in Pregnancy
Mustafa, R., Ahmed, S., Gupta, A., & Venuto, R. C. (2012) · Journal of Pregnancy · doi:10.1155/2012/105918 · Cited by 308
Magnesium sulphate versus diazepam for eclampsia
Duley, L., Henderson-Smart, D. J., Walker, G. J., & Chou, D. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000127.pub2 · Cited by 307
Self-citationStillbirths: what difference can we make and at what cost?
Bhutta, Z. A., Yakoob, M. Y., Lawn, J. E., Rizvi, A., Friberg, I. K., Weissman, E., Buchmann, E., & Goldenberg, R. L. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62269-6 · Cited by 306
Preeclampsia beyond pregnancy: long-term consequences for mother and child
Turbeville, H. R., & Sasser, J. M. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00071.2020 · Cited by 306
SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014
Lowe, S. A., Bowyer, L., Lust, K., McMahon, L. P., Morton, M., North, R. A., Paech, M., & Said, J. M. (2015) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12399 · Cited by 299
Chronic Hypertension in Pregnancy
Seely, E. W., & Ecker, J. (2014) · Circulation · doi:10.1161/circulationaha.113.003904 · Cited by 259
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
Abalos, E., Duley, L., Steyn, D. W., & Gialdini, C. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002252.pub4 · Cited by 242
Self-citationErsbøll, A., Hedegaard, M., Søndergaard, L., Ersbøll, M., & Johansen, M. (2014) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12522 · Cited by 102
Bed rest with or without hospitalisation for hypertension during pregnancy
Meher, S., Abalos, E., & Carroli, G. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003514.pub2 · Cited by 80
Self-citationHypertension in pregnancy: is it time for a new approach to treatment?
Moser, M., Brown, C. M., Rose, C. H., & Garovic, V. D. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283536319 · Cited by 45
Metadata
- Authors
- Abalos, E., Duley, L., Steyn, D. W., & Henderson-Smart, D. J.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2007-01-24
- Issue
- 1
- Pages
- CD002252-CD002252
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W4251795680
- Cited by
- 263
- References
- 138
- Type
- reference entry
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.